Jean‐Pierre Gillet
- Oncology top 5%
- Drug Transport and Resistance Mechanisms 20
- CAR-T cell therapy research 2
- Cancer Research top 10%
- Molecular Biology top 10%
- RNA Interference and Gene Delivery 8
- Hematology top 10%
- Acute Myeloid Leukemia Research 2
- Biomaterials top 10%
-
- Cholangiocarcinoma and Gallbladder Cancer Studies 4
-
- Immunotherapy and Immune Responses 4
-
- HIV/AIDS drug development and treatment 4
-
- Trace Elements in Health 2
- Co-authors
- Michael M. GottesmanFrançoise de LonguevilleDaniel SteinbachThomas EfferthVincent BertholetSusan E. BatesChirayu PatelMaria R. Baer
- Partner nations
- United StatesBelgiumSweden
In The Last Decade
Jean‐Pierre Gillet
29 papers receiving 1.7k citations
Hit Papers
Peers
Comparison fields: 5 of 103
- Oncology 876
- Cancer Research 231
- Molecular Biology 1.0k
- Hematology 127
- Biomaterials 145
Countries citing papers authored by Jean‐Pierre Gillet
This map shows the geographic impact of Jean‐Pierre Gillet's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jean‐Pierre Gillet with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jean‐Pierre Gillet more than expected).
Fields of papers citing papers by Jean‐Pierre Gillet
This network shows the impact of papers produced by Jean‐Pierre Gillet. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jean‐Pierre Gillet. The network helps show where Jean‐Pierre Gillet may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Jean‐Pierre Gillet, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 1 | |
| 2 | 2023 | 2 | |
| 3 | 2023 | 2 | |
| 4 | 2023 | 29 | |
| 5 | 2023 | 7 | |
| 6 | 2022 | 6 | |
| 7 | 2014 | 37 | |
| 8 | Collateral sensitivity to cisplatin in KB-8-5-11 drug-resistant cancer cells. | 2014 | 12 |
| 9 | 2012 | 213 | |
| 10 | 2012 | 20 | |
| 11 | 2011 | 56 | |
| 12 | Mechanisms of Multidrug Resistance in Cancerbreakdown → | 2009 | 569 |
| 13 | 2009 | 126 | |
| 14 | 2009 | 30 | |
| 15 | 2009 | 2 | |
| 16 | 2008 | 51 | |
| 17 | 2006 | 90 | |
| 18 | 2006 | 10 | |
| 19 | 2006 | 52 | |
| 20 | 1989 | 2 |
About Jean‐Pierre Gillet
Jean‐Pierre Gillet is a scholar working on Oncology, Genetics and Molecular Biology, having authored 29 papers that have together received 1.7k indexed citations. Recurring topics across this work include Drug Transport and Resistance Mechanisms (20 papers), RNA Interference and Gene Delivery (8 papers), Cholangiocarcinoma and Gallbladder Cancer Studies (4 papers), Immunotherapy and Immune Responses (4 papers), HIV/AIDS drug development and treatment (4 papers), Acute Myeloid Leukemia Research (2 papers), CAR-T cell therapy research (2 papers) and Trace Elements in Health (2 papers). The work is most often cited by research in Oncology (876 citations), Cancer Research (231 citations) and Molecular Biology (1.0k citations). Jean‐Pierre Gillet has collaborated with scholars based in United States, Belgium and Sweden. Frequent co-authors include Michael M. Gottesman, Françoise de Longueville, Daniel Steinbach, Thomas Efferth, Vincent Bertholet, Susan E. Bates, Chirayu Patel, Maria R. Baer, Brian C. Shaffer and José Remacle. Their work appears in journals such as Clinical Cancer Research, Trends in cancer, PLoS ONE, Blood and Molecular Cancer Therapeutics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.